$4995 | Single User
$9990 | Site License
$14985 | Global License

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition [Report Updated: 19-12-2018]

Published by Global Data: 19 Dec 2018 | 228697 | In Stock

Introduction

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition

Summary

This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Scope

- Helps bio/pharmaceutical manufacturing, development, and supply chain executives understand the implications of M&A activity on their supply base and sourcing options.

- Helps executives at CMOs and associated contract services companies and investors to recognize the significance of M&A activities for the competitive dynamics of the industry and how company strategies must change to address the altering market.

- To gain insights that might enable predictions of the nature and implications of M&A activity in the next three to five years.

Reasons to buy

This 52-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends. This report is required reading for -

- CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking

- Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence

- Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking.

Table of Contents
for PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition [Report Updated: 19-12-2018]

  • Table of Contents

    1. Executive Summary 4

    2 Objectives and Methodology 5

    3 Overview of M&A Activity 2015-2017 6

    Target Characteristics 7

    Acquirer Characteristics 11

    4 Segment Close-Ups of M&A Activity, 2015-2017 15

    Dose Manufacturing 15

    API - Biologic 18

    API - Small Molecule 19

    Analytical Services 21

    Formulation and Clinical Supplies Manufacturing 24

    Packaging 26

    5 Valuations 27

    6 Facility Acquisitions 29

    7 What It Means 36

    8 The Outlook for M&A in the Manufacturing Services Industry 39

    9 Notes on Methodology 41

    10 Appendix 42

    Service Acquisitions 2015-2017 42

    Bibliography 49

    Primary Research - Key Opinion Leaders Cited in this Report 49

    About the Authors 50

List Of Tables
in PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition [Report Updated: 19-12-2018]

List of Tables

Table 1: CMO Services Businesses Acquired as Part of Larger Deals, 2017 6

Table 2: Company Acquisitions by Target Service and Size, 2015-2017 9

Table 3: Company Acquisitions by Target Service and Ownership, 2015-2017 9

Table 4: Company Acquisitions by Target Market Scope and Size, 2015-2017 10

Table 5: Most Active Acquirers, 2015-2017 13

Table 6: Company Acquisitions of Dose Manufacturers, 2015-2017 16

Table 7: Company Acquisitions of API - Biologic Manufacturers, 2015-2017 19

Table 8: Company Acquisitions of API - Small Molecule Manufacturers, 2015-2017 20

Table 9: Company Acquisitions of Analytical Services, 2015-2017 22

Table 10: Company Acquisitions of Formulation Manufacturers, 2015-2017 25

Table 11: Company Acquisitions of Contract Packagers, 2015-2017 26

Table 12: Services Deals with Known Transaction Value and Multiples, 2015-2017 27

Table 13: Facility Acquisitions by CMOs, 2015-2017 33

Table 14: Most Active Acquirers, 2015-2017 36

Table 15: Acquisitions by PE Firms, 2015-2017 37

Table 16: Potential Targets: API - Biologic (Non-Cell and Gene Therapy) Service Providers 39

Table 17: Potential Targets: API - Biologic (Gene and Cell Therapy Only) Service Providers 40

Table 18: Service Acquisitions, 2015-2017 42

List Of Figures, Charts and Diagrams
in PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition [Report Updated: 19-12-2018]

List of Figures

Figure 1: Company Acquisitions by Target Service Offering, 2015-2017 7

Figure 2: Company Acquisitions by Target Revenues, 2015-2017 8

Figure 3: Company Acquisitions by Target Ownership, 2015-2017 8

Figure 4: Acquisition Targets by Sophistication of Capabilities 11

Figure 5: Number of Acquisitions by Acquirer’s Core Business 12

Figure 6: Number of Acquisitions by Acquirer Ownership 13

Figure 7: Number of Acquisitions by Principal Acquirer Motivation 14

Figure 8: Dose Forms Manufactured by Acquired Dose Manufacturers 15

Figure 9: Pharma CMO Facility Acquisitions, 2015-2017 30

Additional Details

Publisher

Global Data

Publisher Information

Reference

228697 | GDPS0024MAR

Number of Pages

52

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2018 Edition
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2018 EditionSummaryT...
05 Apr 2018 by Global Data USD $4,995 More Info
PharmSource: Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2023
PharmSource: Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2023SummaryThi...
14 Feb 2018 by Global Data USD $4,995 More Info
PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2017 Edition
PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share a...
12 Jul 2017 by Global Data USD $2,995 More Info
PharmSource - M&A in the CMC Services Industry: Implications and Outlook
PharmSource - M&A in the CMC Services Industry: Implications and OutlookSummaryM&A is reshaping the ...
11 Apr 2017 by Global Data USD $2,995 More Info
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 EditionSummaryW...
01 Apr 2017 by Global Data USD $2,995 More Info
PharmSource - Follow the Money: The Outlook for Outsourced Spending on Early Development Services
PharmSource - Follow the Money: The Outlook for Outsourced Spending on Early Development ServicesSum...
11 Jan 2017 by Global Data USD $1,995 More Info
PharmSource - Bio/Pharma CapEx Trends 2016
PharmSource - Bio/Pharma CapEx Trends 2016SummaryCaptive capacity remains the largest impediment to ...
16 Sep 2016 by Global Data USD $997 More Info
PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2016 Edition
PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share a...
01 Sep 2016 by Global Data USD $1,975 More Info
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2016 Edition
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2016 EditionSummaryO...
01 Mar 2016 by Global Data USD $1,975 More Info
PharmSource - Market Opportunities for Contract Manufacturers in Antibody Drug Conjugates
PharmSource - Market Opportunities for Contract Manufacturers in Antibody Drug ConjugatesSummaryPhar...
01 Jan 2016 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition [Report Updated: 19-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data